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 Val158Met COMT polymorphism showed an influence on 
personality questionnaires (openness and self-transcen-
dence; NEO Five-Factor Inventory, Temperament and Char-
acter Inventory).  Conclusion: The transcription factor AP-2β 
intron 2 polymorphism had more influence on cognition 
than the MAOA and COMT polymorphisms. Possibly, the AP-
2β genotype might influence cognition through pathways 
other than those that regulate MAOA and COMT transcrip-
tion. Interactions of transcription factor AP-2β, COMT, and 
MAOA polymorphisms suggest higher leverage effects of 
transcription factor AP-2β in subjects with high dopamine 
availability.  Copyright © 2013 S. Karger AG, Basel 
 Introduction 
 Transcription factors are proteins that regulate genet-
ic transcription by binding to the promoter regions of 
genes. In the brain, the transcription factor AP-2β is 
widely involved in the synthesis of proteins, some of 
which are a part of the catecholaminergic and serotoner-
gic transmission system. Accordingly, the synthesis of re-
ceptors, transporters, and enzymes within the dopamine 
system are affected by AP-2β-mediated regulation. It has 
previously been reported that a polymorphic region of the 
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 Abstract 
 Background: The transcription factor AP-2β has been shown 
to impact clinical and neuropsychological properties. Appar-
ently, it regulates the transcription of genes that code for 
molecules which are part of the catecholaminergic transmis-
sion system. This investigation focuses on possible effects of 
the transcription factor AP-2β intron 2 polymorphism on 
cognitive performance parameters.  Methods: This hypothe-
sis-driven investigation examined the effects and interac-
tions of the transcription factor AP-2β intron 2 polymor-
phism, the Val158Met catechol- O -methyltransferase (COMT) 
polymorphism, and the variable number of tandem repeat 
polymorphism of monoamine oxidase A (MAOA) on cogni-
tive performance parameters within a group of 200 healthy 
women (age: mean ± SD, 23.93 ± 3.33 years).  Results: The 
AP-2β polymorphism significantly influenced cognitive per-
formance (in particular, the Trail Making Test part B), where-
as the MAOA and COMT polymorphisms did not. However, 
there was an interaction effect of the AP-2β × MAOA × COMT 
genotypes on the decision bias β of the degraded-stimu-
lus version of the continuous performance task. Only the 
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AP-2β gene exists and that this region consists of a vari-
able number of [CAAA] repeats in the second intron of 
the gene, which is located on chromosome 6p12–p21.1 
 [1] . This sequence is repeated either 4 or 5 times  [2, 3] .
 Previous studies have suggested that this AP-2β poly-
morphism is involved in several clinical and neurobio-
logical parameters  [4–6] . The AP-2β polymorphism is 
also associated with binge eating disorder; frequencies of 
homozygotic carriers of the long allele (5/5 [CAAA]) are 
higher in patients suffering from binge eating  [7] . Fur-
thermore, in healthy subjects, long-allele carriers exhibit 
lower scores on questionnaires that reflect anxiety-relat-
ed personality traits and indirect aggression  [1] . Finally, 
lower platelet monoamine oxidase B activity is associated 
with homozygote long-allele carrier status. In rats, the 
AP-2β genotype has been shown to have an impact on 
dopamine and serotonin metabolism in the frontal cortex 
 [5] . Additionally, only females with 2 short alleles show 
decreased homovanillic acid (HVA) concentrations in 
the cerebrospinal fluid compared to carriers with at least 
1 long allele  [2] . These results suggest a substantial rele-
vance of AP-2β in dopaminergic turnover and transmis-
sion. Other studies have indicated that a high dopamine 
synthesis capacity is supportive to maximize cognitive 
performance most probably by enabling an optimal mod-
ulation of dopamine signaling  [8, 9] . Following this line 
of reasoning, the AP-2β intron 2 polymorphism might 
be involved in individual cognitive performances. To the 
best of our knowledge, there are no previous studies that 
have investigated the influence of AP-2β on cognitive 
performance. We hypothesize that subjects with the 
4/4-repeat AP-2β genotype show better cognitive perfor-
mance compared to 5/5 carriers because the above-men-
tioned  [2] decreased HVA levels in 4/4 carriers are 
thought to depict a lower dopamine metabolism by 
monoamine oxidase (MAO) enzymes, the formation of 
which is under control of AP-2β. Under these premises, 
lower HVA levels might be a surrogate marker for higher 
capacities of dopamine transmission. The latter was con-
sistently described to be associated with better cognitive 
performance  [9–11] .
 Given the AP-2β intron 2 polymorphism would show 
a relevant effect on cognition via modulations of the do-
pamine metabolism, it might be hypothesized that other 
well-described polymorphisms that influence the path-
ways of dopamine degradation could exert additional ef-
fects. Some investigations were performed that focused 
on a polymorphism of the enzyme catechol- O -methyl-
transferase (COMT, Val158Met polymorphism;  rs4680 ); 
COMT is an important enzyme of dopamine metabolism 
(for a review, see Barnett et al.  [12] ). Together with MAO, 
it is responsible for the degradation of dopamine into 
HVA. With respect to the COMT polymorphism, some 
authors reported that the Val alleles contribute to states 
of lower cognitive performance due to higher metabolism 
rates. Whereas some groups propose that the trimodal 
distribution of COMT activity results in such differences 
of cognition, other authors reported no effects  [13–15] . A 
meta-analysis of Barnett et al.  [12] found no or very little 
effect of COMT on cognitive performance.
 The well-known variable number of tandem repeat 
(VNTR) MAOA polymorphism might theoretically also 
modulate the cognitive performance by different enzyme 
activities and different capacities of the dopamine trans-
mission system. Whereas some studies focused on the be-
havioral impact of the VNTR MAOA polymorphism, no 
relevant investigation has been performed on cognition 
yet. Before the background of recent research results, 
strong effects of these COMT and MAOA polymor-
phisms could not be anticipated. However, it might be 
possible that lower enzyme activities of MAOA and 
COMT (e.g. COMT [Met/Met] and MAOA [3/3 VNTR]) 
could sum up to the postulated AP-2β effects (see before). 
Therefore, the proposed functional interplay between the 
AP-2β, COMT, and MAOA polymorphisms was investi-
gated in a sample of 200 healthy female subjects. All sub-
jects were genetically characterized and performed cogni-
tive tasks which were previously shown to be sensitive to 
dopaminergic transmission.
 Methods 
 Subjects 
 This study was approved by the Ethics Committee of the Med-
ical Faculty of RWTH Aachen University. All subjects were re-
cruited by advertisements in public institutions. A total of 200 un-
related healthy females were included in the study after they had 
given written informed consent to participate. The mean age ± SD 
was 23.93  ±  3.33  years. After an initial screening of 306 subjects by 
telephone conversation, 206 subjects were invited to attend the 
initial examination/visit (study information, check for inclusion/
exclusion criteria). The major exclusion criteria were mental dis-
orders (according to the  Diagnostic and Statistical Manual of Men-
tal Disorders,  fourth edition, including nicotine dependence/
abuse), somatic disorders, and the psychiatric treatment of first-
degree relatives. The inclusion criteria consisted of Caucasian ori-
gin, right-handedness, nonsmoker status, and age between 20 and 
35 years. Six subjects failed to meet the inclusion criteria and were 
therefore excluded. The remaining 200 subjects underwent a neu-
ropsychological test battery. An EDTA-anticoagulated blood sam-
ple (10 ml) was drawn from each subject for genotype analysis.
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 Cognitive Assessment 
 The primary intention of the cognitive test battery was to in-
vestigate the individual’s prefrontal executive function, including 
sustained/divided attention, set-shifting capability, working mem-
ory, and psychomotor speed. This was based on previous investi-
gations that successfully correlated the in vivo parameters of do-
pamine synthesis capacity with individual cognitive performance 
results  [9] . We used the Stroop test  [16] , the Trail Making Test part 
B (TMT-B)  [17] , and a degraded-stimulus version of the continu-
ous performance task (dsCPT) in combination with signal detec-
tion theory (adapted from Kathmann et al.  [18] ). When perform-
ing the latter test, 360 pictures were presented on a 21-inch screen. 
A total of 180 of these pictures showed a well-perceptible cross 
(‘+’), and 180 pictures showed the digits ‘0’–‘9’. The picture repre-
senting the ‘0’ was defined as the target digit. Half of the 180 digits 
had well-perceptible contours, whereas the other half of the digits 
were presented with markedly blurred contours. Each digit was 
followed by a cross. The sequence of digits was randomly assigned 
with respect to the choice of digit (‘0’–‘9’) and their perceptibility 
(blurred vs. clear). After every presentation, an interstimulus in-
terval of 1 s was interposed. The subject was instructed to press a 
button (independently from the sharpness) as fast as possible every 
time the digit ‘0’ or a cross (‘+’) was presented. The pictures were 
shown in blocks of 120 (60 digits and 60 crosses) presentations 
with 15-second breaks; the complete test took 12 min. The main 
outcome parameter was the percentage of correctly identified 
blurred ‘0’ digits. Crosses and nonblurred ‘0’ digits were included 
only for the validation of the subject’s compliance.
 The dsCPT was analyzed according to the signal detection the-
ory  [19] . Therefore, the parameters for hits, missed false alarms, 
and correct rejections were entered into the analysis using the 
BayesSDT software package for Matlab  [20] .
 Personality Assessment 
 We additionally examined the personality traits of the subjects 
with the German version of the NEO Five-Factor Inventory (FFI) 
 [21] and the short version of the Temperament and Character In-
ventory (TCI)  [22] .
 Genotyping 
 Genomic DNA was isolated from peripheral lymphocytes with 
a routine salting-out procedure. For the determination of the AP-
2β and MAOA genotypes, standard polymerase chain reaction 
(PCR) amplifications were performed in a 25-μl volume contain-
ing 80 ng of genomic DNA, 1 unit of recombinant  Taq polymerase 
(Invitrogen, Germany), PCR buffer (10 m M Tris-HCl, 50 m M KCl, 
2.5 m M MgCl 2 , pH 8.3), 200 m M dNTPs, and 20 pmol of each 
primer. The AP-2β primer sequences were obtained from Dam-
berg et al.  [1] , and the MAOA primers were obtained from Sabol 
et al.  [23] . For both variants, the forward primers were carboxyflu-
orescein-labeled. The PCR was run on an MJ PTC200 Tempera-
ture Cycler (Biozym, Germany), and each of the 35 cycles consist-
ed of a 95   °   C denaturation step for 45 s, a 63   °   C (AP-2β)/62   °   C 
(MAOA) annealing step for 30 s, and, finally, a 72   °   C elongation 
step for 90 s. PCR products were run on an automated sequencing 
system (AB3130, Applied Biosystems, USA), and the electrophe-
rograms were analyzed with gene mapping software (Applied Bio-
systems, USA).
 The COMT Val158Met genotypes were determined with a py-
rosequencing assay. The region of interest was amplified using the 
same standard PCR conditions as those described above. Primer 
sequences were the following: COMT_Pyro_F (5 ′ -CCCAGCG-
GATGGTGGATTT-3 ′ ) and COMT_Pyro_S (5 ′ -GCGGATG-
GTGGATTT-3 ′ ). The PCR amplification was performed as de-
scribed for the AP-2β analysis, except the annealing temperature 
was 57   °   C. After amplification, single strands were prepared with 
the Vacuum Prep Tool (Biotage, Uppsala, Sweden), which was fol-
lowed by a denaturation step at 85   °   C for 2 min and the final se-
quencing primer hybridization (primer: COMT_Pyro_R: biotin-
5 ′ -CCTTTTTCCAGGTCTGACAACG-3 ′ ). Pyrosequencing was 
conducted with the PyroMark Gold Q96 reagents kit (Biotage AB).
 Based on the results of Damberg et al.  [1] , we genetically  defined 
the following 3 subgroups according to the individual [CAAA] re-
peat status of AP-2β: the homozygote 4/4-repeat allele combina-
tion (short alleles), the heterozygote 4/5-repeat allele group, and 
the homozygote 5/5-repeat allele carriers (long allele). Addition-
ally, the subjects were subdivided into high-, medium-, or low-
activity groups for the VNTR MAOA polymorphism and the 
COMT polymorphism. For the VNTR MAOA genotype, 3/3-re-
peat homozygotes were designated as low-activity, 3/3.5 or 3/4 het-
erozygotes were designated as medium-activity, and genotypes 
with 2 copies of the 3.5- or 4-repeat alleles were designated as high-
activity subjects. The  COMT Val158Met allele combination Met/
Met was designated as low activity, the Val/Met combination was 
designated as medium, and the Val/Val allele combination was 
designated as high activity.
 Statistical Analyses 
 In order to investigate the main effects of the 3 genotypes (AP-
2β, COMT, and MAOA) on cognition and personality, one-way 
ANOVAs were performed on the mean differences between the 
high-, medium-, and low-activity groups. In cases exhibiting sig-
nificant results, a Sidak post hoc analysis was performed. In order 
to correct for multiple testing with respect to the number of cogni-
tive tasks (dsCPT, TMT-B, Stroop), a Bonferroni correction was 
also performed: p values less than 0.016 were considered to be sta-
tistically significant.
Table 1.  Group characteristics regarding AP-2β, MAOA, and 
COMT genotypes
AP-2β 4/4 [CAAA], n 4/5 [CAAA], n 5/5 [CAAA], n
24 (12%) 106 (53%) 69 (34.5%)
MAOA High, n Medium, n Low, n
91 (45.5%) 90 (45.0%) 19 (9.5%)
COMT Met/Met, n Val/Met, n Val/Val, n
67 (33.5%) 94 (47%) 39 (19.5%)
Distribution of AP-2β, MAOA, and COMT genotypes in the 
group of 200 female subjects. MAOA-low alleles = 3/3; MAOA-
medium alleles = 3/3.5 and 3/4; MAOA-high alleles = 3.5/3.5 and 
4/4.
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 In order to analyze the interactions of the 3 polymorphisms, a 
generalized linear model was applied for all of the main outcome 
variables for the Stroop, dsCPT hits, decision bias (β), and TMT-B 
tests. The model included the 3 genetic main effects as predictors, 
age as a covariate, and the 2 gene × gene interaction terms.
 The Hardy-Weinberg equilibrium was analyzed with a web 
tool by Rodriguez et al.  [24] .
 Results 
 Gene Frequencies 
 The allele frequencies for the variable number of AP-
2β [CAAA] sequences were 38.5% (n = 154) for 4 × 
[CAAA] and 61.3% (n = 245) for 5 × [CAAA], and there 
was 1 rare variation (0.3%). The VNTR MAOA polymor-
phism allele frequencies were 3-repeat [31.8% (n = 127)], 
3.5-repeat [1.8% (n = 7)], 4-repeat [65.3% (n = 261)], and 
5-repeat [1.3% (n = 5)]. The allele frequencies for the 
COMT Val158Met genotypes were 43% (n = 172) for the 
Val allele and 57% (n = 228) for the Met allele. See  table 1 
for the group frequencies of the polymorphisms or ge-
netic groups, respectively. All polymorphisms were in 
Hardy-Weinberg equilibrium (AP-2β: χ 2 = 3, p > 0.05; 
MAOA: χ 2 = 0.34, p > 0.05; COMT: χ 2 = 0.34, p > 0.05). 
No significant differences were found for age or educa-
tional level in the 3 genetic groups.
 Cognitive Measurements 
 The one-way ANOVA for the AP-2β polymorphism 
revealed a significant main effect on the TMT-B results 
(F = 4.831, d.f. = 2, p = 0.009, n = 199;  table 2 ). The Si-
dak post hoc analyses revealed that the 4/4 (40.33 ± 9.01) 
carriers performed better than the 5/5 carriers (49.77 ± 
11.29; p = 0.007) and the 4/5 carriers (47.62 ± 14.39; p = 
0.038) (for details, see  table 3 and  fig. 1 ). The other cogni-
tive tests did not show any significant group differences. 
The group difference between 4/4 and 5/5 carriers sur-
vived Bonferroni correction for the inclusion of multiple 
cognitive tasks.
 The MAOA and COMT polymorphisms exhibited no 
significant effects on the performances of the cognitive 
tasks in the present sample.
Table 2.  One-way ANOVA of the cognitive performance and AP-2β, MAOA and COMT
Measure  F d.f. p value
MAOA  high medium low
TMT-B, s 53.37 (91) 46.38 (90) 47.26 (19) 2.296 2 0.103
Stroop interference, s 68.56 (91) 63.01 (90) 65.49 (19) 2.141 2 0.120
dsCPT hits 6.31 (91) 5.68 (89) 5.71 (19) 0.576 2 0.563
 Decision bias β 0.08 (91) 0.34 (89) 0.36 (19) 1.484 2 0.229
COMT  Met/Met Val/Met Val/Val
TMT-B, s 49.81 (67) 46.70 (94) 45.18 (39) 1.852 2 0.160
Stroop interference, s 64.96 (67) 64.67 (94) 64.13 (39) 0.059 2 0.943
dsCPT hits 5.91 (67) 5.56 (93) 5.97 (39) 0.620 2 0.539
Decision bias β 0.30 (67) 0.39 (93) 0.22 (39) 0.947 2 0.390
AP-2β  4/4 [CAAA] 4/5 [CAAA] 5/5 [CAAA]
TMT-B, s 40.33 (24) 47.62 (106) 49.77 (69) 4.831 2 0.009**
Stroop interference, s 62.63 (24) 65.03 (106) 64.55 (69) 0.40 2 0.671
dsCPT hits 5.62 (24) 5.78 (105) 5.84 (69) 0.073 2 0.929
 Decision bias β 0.55 (24) 0.29 (105) 0.31 (69) 1.461 2 0.235
 Results of the ANOVA for AP-2β, MAOA and COMT and the neuropsychological test battery, which consists 
of TMT-B, Stroop interference, dsCPT hit rate, and the decision bias β resulting from the signal detection theo-
ry analysis of the dsCPT. MAOA-low alleles = 3/3, MAOA-medium alleles = 3/3.5 and 3/4, and MAOA-high al-
leles 3.5/3.5 and 4/4. ** p < 0.01. Figures in parentheses indicate numbers.
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 Personality Assessment 
 The COMT polymorphism showed main effects on 
some dimensions of the NEO-FFI and TCI. The openness 
item in the NEO-FFI revealed a main group effect (F = 
3.575, d.f. = 2, p = 0.030, n = 198). The corresponding post 
hoc analysis indicated that the Val/Val group showed sig-
nificantly higher scores when compared to the Val/Met 
group (p =  0.036) (for results, see  table 4 ) but not when 
compared to the Met/Met group. Within the TCI, the 
self-transcendence subscale was significantly influenced 
by COMT (F = 3.329, d.f. = 2, p = 0.038, n = 170). Further 
analysis showed that the Met/Met group had significant-
ly lower scores than the Val/Val group (27.45 ± 12.79 vs. 
35.68 ± 16.54, p  =  0.033) ( table 5 ).
 No significant effects on personality were found for 
the AP-2β and MAOA polymorphisms.
 Furthermore, a negative correlation between decision 
bias β and neuroticism of the NEO-FFI exists (r = –1.46, 
p = 0.04); there were no significant correlations between 
β and any further personality items.
Table 3.  Sidak post hoc analyses for the cognitive tasks and AP-2β, MAOA and COMT
AP-2β Group 4/4 – 5/5  Group 4/4 – 4/5   Group 4/5 – 5/5
mean difference p  mean difference p  me an difference p
TMT-B –9.435 0.007** –7.289 0.038* –2.145 0.628
Stroop interference n.s. n.s. n.s. n.s. n.s. n.s.
dsCPT hits n.s. n.s. n.s. n.s. n.s. n.s.
Decision bias β n.s. n.s.  n.s. n.s.  n.s. n.s.
COMT Group Met/Met–Val/Val  Group Met/Met–Val/Met  Group Val/Met–Val/Val
 mean difference p  mean difference p  mean difference p
TMT-B n.s. n.s. n.s. n.s. n.s. n.s.
Stroop interference n.s. n.s. n.s. n.s. n.s. n.s.
dsCPT hits n.s. n.s. n.s. n.s. n.s. n.s.
Decision bias β n.s. n.s.  n.s. n.s.  n.s. n.s.
MAOA Group low–high Group low–middle Group middle–high
  mean difference p  mean difference p  mean difference p
TMT-B n.s. n.s. n.s. n.s. n.s. n.s.
Stroop interference n.s. n.s. n.s. n.s. n.s. n.s.
dsCPT hits n.s. n.s. n.s. n.s. n.s. n.s.
Decision bias β n.s. n.s.  n.s. n.s.  n.s. n.s. 
 Post hoc analyses for AP-2β MAOA and COMT and the neuropsychological test battery consisting of TMT-
B, Stroop interference score, dsCPT hit rate, and the decision bias β resulting from the signal detection theory 
analysis. MAOA-low alleles = 3/3, MAOA-medium alleles = 3/3.5 and 3/4, and MAOA-high alleles 3.5/3.5 and 
4/4. * p < 0.05; ** p < 0.01; n.s. = not significant.
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 Fig. 1. AP-2β and TMT-B. Mean time of TMT-B in seconds. AP-
2β divided into groups based on the [CAAA] repetition.  *  p < 0.05; 
 * *  p < 0.01. Error bars: 95% confidence interval. 
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 Interactions 
 In order to investigate the possible interactions be-
tween the genes, the main effects of the AP-2β, MAOA, 
and COMT genotypes, as well as the interaction terms 
AP-2β × MAOA, AP-2β × COMT, and AP-2β × MAOA 
× COMT, with age as a scaled covariate, were tested in a 
generalized linear model. Highly significant main effects 
were found for all 3 polymorphisms: AP-2β, MAOA, and 
COMT (χ 2 = 7.466, p = 0.024; χ 2 = 11.675, p = 0.003; χ 2 = 
9.111, p  =  0.011, respectively). Furthermore, there were 
interaction effects of AP-2β and MAOA and for AP-2β, 
MAOA, and COMT (χ 2 = 12.044, p = 0.017; χ 2 = 25.923, 
p  =  0.004, respectively;  table 6 ). Post hoc t tests for the 
AP-2β × MAOA interaction showed that, in the high-
activity MAOA group, a significant difference in deci-
sion bias existed between the 4/4 AP-2β carriers and the 
4/5 carriers (t = 2.431, p = 0.018). The 4/4 carriers showed 
a more conservative bias, whereas the 4/5 carriers showed 
only a minimally conservative bias. Due to the genetic 
distribution and allele frequencies, some genetic interac-
tion clusters consisted of less than 2 subjects (see  fig. 3 
for AP-2β × MAOA interaction). No reasonable inter-
Table 4.  ANOVA of personality questionnaires and COMT
 COMT F d.f. p value
 Met/Met Val/Met Val/Val
NEO-Five-Factor Inventory (n = 66) (n = 94) (n = 38)
Neuroticism 1.41 1.26 1.31 1.577 2 0.209
Extraversion 2.62 2.64 2.53 0.710 2 0.493
Openness 2.69 2.57 2.78 3.575 2 0.030*
Agreeableness 2.88 2.92 2.86 0.334 2 0.717
Conscientiousness 2.79 2.82 2.84 0.082 2 0.921
Temperament and Character Inventory (n = 54) (n = 81) (n = 35)
Novelty seeking 41.37 39.42 37.03 2.406 2 0.093
Harm avoidance 30.74 30.99 35.74 1.611 2 0.203
Reward dependence 51.44 52.14 50.00 0.555 2 0.575
Persistence 46.39 48.99 48.06 0.976 2 0.379
Self-directedness 59.72 63.17 60.94 1.769 2 0.174
Cooperativeness 64.96 65.25 62.94 0.870 2 0.421
Self-transcendence 27.45 31.38 35.68 3.329 2 0.038*
 * p < 0.05.
Table 5.  Results of the Sidak post hoc test for TCI and COMT
TCI  COMT
 
group Met/Met vs. Val/Val  group Met/Met vs. Val/Met group Val/Met vs. Val/Val
mean difference p mean difference p mean difference p
Novelty seeking n.s. n.s. n.s. n.s. n.s. n.s.
Harm avoidance n.s. n.s. n.s. n.s. n.s. n.s.
Reward dependence n.s. n.s. n.s. n.s. n.s. n.s.
Persistence n.s. n.s. n.s. n.s. n.s. n.s.
Self-directedness n.s. n.s. n.s. n.s. n.s. n.s.
Cooperativeness n.s. n.s. n.s. n.s. n.s. n.s.
Self-transcendence –8.22 0.033*  –3.92 0.349  4.30 0.390
 n.s. = Not significant; * p < 0.05.
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pretations can be drawn from these clusters. Never-
theless, these findings with respect to the decision bias
encourage performing replication studies with larger 
sample.
 The post hoc analyses for the AP-2β × MAOA × 
COMT interaction revealed that there was a significant 
difference in the decision bias between the MAOA high-
activity group (MAOA-H) × COMT (Val/Met) × 5/5 AP-
2β and the MAOA low-activity group (MAOA-L) × 
COMT (Val/Met) × 5/5 AP-2β, which showed that the 
MAOA-L group had a liberal bias, whereas the MAOA-H 
group showed a more conservative bias. Further post hoc 
tests exhibited a significant difference for the MAOA-H 
× COMT (Val/Met) group between the 4/5 AP-2β and 5/5 
AP-2β carriers (t = –2.717, p = 0.01), resulting in a more 
conservative bias for group 5/5. The difference between 
the 4/5 and 5/5 carriers in the MAOA-L × COMT (Val/
Met) group showed an even stronger significance (t = 
Table 6.  Generalized linear model analysis for the neuropsychological tests: relationship between AP-2β, MAOA and COMT
 TMT-B (n = 199) Stoop interference (n = 199) dsCPT hits (n = 198) Liberal bias β (n = 198)
Wald χ2 d.f. p Wald χ2 d.f. p Wald χ2 d.f. p Wa ld χ2 d.f. p
Main effects
AP-2β 3.692 2 0.158 0.367 2 0.832 0.689 2 0.709 9.765 2 0.008
MAOA 1.774 2 0.412 2.378 2 0.304 2.588 2 0.274 14.595 2 0.001**
COMT 0.020 2 0.990 0.466 2 0.792 4.027 2 0.134 11.453 2 0.003**
Age 0.004 1 0.952 2.324 1 0.127 1.991 1 0.158 0.936 1 0.333
Interactions
AP-2β × MAOA 0.920 4 0.922 4.596 4 0.331 2.515 4 0.642 9.988 4 0.041
AP-2β × COMT 6.833 4 0.145 6.447 4 0.168 5.58 4 0.233 7.462 4 0.113
AP-2β × MAOA × COMT 6.446 10 0.776  10.714 10 0.380  18.025 10 0.055  32.826 10 0.000**
 Results of generalized linear model analysis of AP-2β, MAOA and COMT and the interaction terms AP-2β × MAOA, AP-2β × COMT 
and AP-2β × MAOA × COMT on the 4 neuropsychological tests TMT-B, Stroop interference, dsCPT hit rate and decision bias β. Age 
is included as covariate. ** p < 0.01.
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8.636, p = 0.003). The 5/5 carriers showed a liberal bias, 
whereas the 4/5 carriers had a conservative bias. The 
MAOA-L × COMT (Val/Met) × 5/5 AP-2β group had a 
significantly more liberal bias than almost every other 
combination with the 5/5 Ap-2β allele (see  fig. 4 for AP-
2β × MAOA × COMT interaction).
 Besides these effects on the decision bias, a borderline-
significant interaction between AP-2β, MAOA, and 
COMT for the hit rate of the dsCPT was shown (χ 2 = 
18.025, d.f. = 10; p = 0.055).
 There were no effects for the TMT-B or the Stroop 
 interference task. After very conservative correction 
for multiple testing, including all test modalities, assess-
ments, and genotypes, no significant group differences 
could be observed.
 Discussion 
 In the present study, we investigated the effects of the 
polymorphisms of AP-2β, MAOA, and COMT on the 
cognitive performance and personality dimensions of a 
sample of 200 healthy female subjects. The choices of the 
polymorphisms and the study protocol were strictly hy-
pothesis-driven by the postulated tight functional inter-
play of their corresponding gene products on the metab-
olism of catecholamines.
 The main finding was a positive group effect of the 
AP-2β genotype on the TMT-B, which is a task that pre-
viously showed robust associations with dopaminergic 
in vivo parameters  [9] . The corresponding post hoc anal-
ysis indicated that those individuals with 2 short alleles 
performed better on the TMT-B than the heterozygote 
and homozygote long-allele subjects. Interestingly, the 
group effects of the MAOA promoter polymorphism, as 
well as the rs4680 COMT polymorphism, showed far less 
pronounced and nonstatistically significant associations 
with cognitive performance, even though several (but 
not all) previous investigations reported a reliable influ-
ence of these genotypes on catecholaminergic metabo-
lism  [12, 13, 25] . Nevertheless, Damberg et al.  [2] ob-
served that females who are homozygotic for the short 
allele showed lower HVA levels than subjects with at least 
1 long allele. Thus, the AP-2β genotype appears to be 
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functionally relevant to dopamine metabolism, poten-
tially by modulating the transcription of the MAOA 
gene. Indeed, most of the previous investigations have 
reported a positive association of HVA concentrations 
and cognitive outcome parameters. This has mainly been 
interpreted to be caused by variations in dopamine syn-
thesis. An AP-2β-associated reduction of MAOA  [2] and 
COMT transcription might reduce dopamine metabo-
lism, resulting in lower dopamine turnover rates and in-
creased dopamine availability because less dopamine 
is degraded into HVA. In general, most healthy subjects 
would benefit from high dopaminergic capacities  [9] . 
The results of the Stroop task were similar but failed to 
reach statistical significance. However, due to our COMT 
and MAOA results, it is critical to explain the AP-2β ef-
fects through the possible modulation of the transcrip-
tion of a single metabolic enzyme.
 The VNTR MAOA polymorphism is functionally able 
to interfere with dopamine metabolism. Furthermore, it 
has previously been described to affect intelligence, ag-
gression, risk taking, antisocial behavior, and treatment 
response  [26–29] . In our sample, there were no signifi-
cant effects on the cognitive performance parameters; 
however, we found a trend-like relationship. Interesting-
ly, this relationship was counterintuitive: high-activity al-
lele carriers showed slightly better cognitive results in the 
TMT-B and the Stroop task. Earlier studies have indicat-
ed that high-activity allele carriers should have lower do-
pamine levels and higher dopamine turnover. Neverthe-
less, our results were consistent with a previous report in 
healthy subjects that showed that MAOA-H carriers have 
a higher IQ compared with MAOA-L carriers  [26] .
 Finally, we did not find any effects of COMT on 
 executive functioning. There are some inconsistencies 
among previous investigations as to whether the COMT 
Val158Met polymorphism has a significant impact on in-
dividual cognitive performance. A meta-analysis by Bar-
nett et al.  [12] that included 46 studies concluded that the 
COMT polymorphism has only a small influence, if any, 
on cognitive performance. Our findings supported these 
results. It might be that the COMT polymorphism does 
not explain a significant proportion of individual perfor-
mances while subjects are executing tasks that demand 
attention, set shifting, and working memory abilities. The 
absent or counterintuitive results in the present sample 
for the COMT Val158Met and VNTR MAOA polymor-
phisms do not support the idea that the AP-2β polymor-
phism exerts its effect on cognition simply through 
COMT and MAOA modulation, as previously thought. 
The direct effects of AP-2β on cognitive performance in 
the absence of any effects of COMT/MAOA suggest that 
the physiological mechanisms that are involved in the 
AP-2β association are not entirely based on the rate of 
dopamine metabolism but may also depend on the mod-
ulation of the transcription of various other gene prod-
ucts that are involved in signal transduction in the central 
nervous system.
 The generalized linear model analysis, however, elu-
cidated that decision bias (β), in particular, was highly 
affected by multiple genotypes. All 3 polymorphisms 
showed significant main effects. Furthermore, the inter-
action of AP-2β, MAOA, and COMT (χ 2 = 32.826, p < 
0.005) showed a strong impact. These data suggested 
that the functional interplay between the corresponding 
gene products modulated the subject’s decision making 
through dopamine metabolism. The decision bias pro-
vided a measure of whether decisions were generally 
more conservative or liberal. A score of 0 meant that there 
was no response bias, a positive score indicated a bias to-
wards saying ‘no’, whereas a negative score indicated a 
bias towards saying ‘yes’  [20, 30] . Looking at the results, 
simple interpretations of the high- or low-activity geno-
types were not applicable as low MAOA subjects tended 
to show no bias and low COMT activity subjects showed 
a more conservative bias. Including the AP-2β promoter 
polymorphism in the statistical model provided a neces-
sary factor for the interpretation of the model results. The 
MAOA-L/COMT (Val/Met)/AP-2β 5/5 carriers showed 
a more liberal bias compared to all other MAOA/COMT/
AP-2β 5/5 groups. Because none of the 3 polymorphisms 
showed a liberal bias, it may be concluded that the inter-
action of the 3 genes turned the conservative or neutral 
biases into a more liberal one. These results need to be 
interpreted with caution due to the fact that some gene 
combinations had a very small group size (n < 2). Since 
some gene/allele frequencies are comparatively low, the 
presence of rare gene combinations is consequential. In 
fact, the actual group sizes (gene combinations) do not 
relevantly differ from the calculated and expected sizes. It 
may be speculated that the transcription rates of the AP-
2β polymorphism had the most prominent effect in the 
group with the highest dopamine availability (MAOA-L/
COMT-Val/Met). A study by Vernaleken et al.  [31] sup-
ports this interpretation. In that positron emission to-
mography study, subjects with high baseline D 2/3 receptor 
availability initially show better cognitive performance. 
However, when the dopamine system is challenged with 
ketamine, they show the highest level of drug-induced 
impairments. Thus, one might speculate that a subject 
with high levels of dopamine might be more vulnerable 
 Schabram  /Eggermann  /Siegel  /Gründer  /
Zerres  /Vernaleken  
 
Neuropsychobiology 2013;68:79–90
DOI: 10.1159/000350997
88
to manipulations of the structures, metabolism, or envi-
ronmental stress. Nevertheless, it is more likely that these 
interactions involve complex neurobiological interac-
tions of diverse structures rather than depict unidirec-
tional and circumscribed mechanisms of the hierarchical 
pathway (i.e., transcription factor  → MAOA/COMT 
transcription  → MAOA/COMT activity  → dopaminergic 
availability).
 However, there is a negative correlation between neu-
roticism and decision bias β. Higher neuroticism is asso-
ciated with less conservative bias/greater liberal bias.  The 
decision bias β is a value of the individual’s weighing how 
to make the right decision. Subjects with more liberal bias 
tend to rather interpret a degraded stimulus as correct hit 
than to take the chance of omission. Subjects with more 
conservative bias, on the other hand, want to be rather 
sure that a degraded stimulus is unambiguously a correct 
target. The present correlational findings are in line with 
the literature: Burton et al.  [32] found that neuroticism is 
negatively correlated with the decision bias β. Further-
more, they also found that in females the bias is negative-
ly correlated with openness: higher scores of openness are 
associated with more liberal decisions. This association 
between these complex measures of personalities (mainly 
reflecting aspects of impulsivity) with distinct outcome 
parameters of a circumscribed cognitive task is astonish-
ing but intuitive in its direction.
 The current investigation also described a possible 
 relationship between AP-2β/MAOA/COMT polymor-
phisms and personality factors. Based on the known lit-
erature, it is hypothesized that some subscales of person-
ality questionnaires are associated with the dopamine 
system. Especially, novelty seeking and extraversion are 
suggested to be affected by dopamine transmission  [33–
36] . These results, however, highly depend on the choice 
of assessment tools. In this sample, carriers of the Val/Val 
allele of the COMT polymorphism showed significantly 
lower scores on the self-transcendence subscale in the 
character part of the TCI compared to Met/Met and Val/
Met carriers. Comings et al.  [37] found that this subscale 
is sensitive to some genes that are involved in the dopa-
minergic system, including COMT. Similarly, in our 
sample, the Val/Val group scored higher on the NEO-FFI 
subscale of openness to experience, which has also been 
hypothesized to be associated with the dopaminergic sys-
tem  [38] . However, additional results of Deyoung et al. 
 [39] present the opposite results of COMT and openness 
with Met/Met carriers having higher scores of openness 
compared to the Val/Val group. Our results showed only 
a marginal difference between the 2 groups, even though 
this was a significant result. However, the previous study 
tested children who were aged between 8 and 13 years, 
who were non- or maltreated, and who grew up under 
low-income conditions  [39] . In the present study, healthy 
female subjects (mainly students) were included, and this 
might suggest a bias of environmental or developmental 
factors. However, no socioeconomic data were system-
atically collected. Further investigations are needed to 
clarify this. Contrary to our expectation, there was no re-
lationship between extraversion, novelty seeking, and the 
genotypes. This might be due to several reasons. As men-
tioned before, questionnaires differ in their ability to de-
lineate personality traits complying with underlying neu-
robiological mechanisms. It is possible that the present 
choice of questionnaires which represents our standard 
protocol is not optimal to depict dopamine-related per-
sonality traits. Furthermore, it remains unclear whether 
the strict exclusion of male subjects impacts the results. 
Otherwise, there are previous studies which were also un-
able to find associations between the dopamine system 
(or AP-2β) and novelty seeking  [36, 40] .
 In the present population, there were no effects of AP-
2β on personality. Alternatively, a previous study of Dam-
berg et al.  [1] indicated that AP-2β influences anxiety-
related traits. Several reasons may account for this dis-
crepancy. The sample sizes were comparatively low in 
both studies, and differences in inclusion criteria might 
be a relevant factor. Finally, Damberg et al.  [1] used the 
Karolinska Scales of Personality, whereas, in this investi-
gation, the NEO-FFI and the TCI were used. Another 
study of Damberg et al.  [40] that used the TCI and the 
NEO-PI-R did not detect any associations either. A rele-
vant impact of the AP-2β genotype on personality traits 
thus remains in question.
 In summary, the AP-2β genotype is an important 
modulating factor of structures related to dopaminergic 
transmission. The data indicated that AP-2β had more 
influence on cognition than MAOA and COMT. Because 
MAOA and COMT showed little effect on cognition, we 
propose that AP-2β might influence cognition through 
pathways other than those that regulate MAOA and 
COMT.
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